-
Billy Boyle
News
Contract Win to develop Portable Breath Device
Jun 21 2023
The US Defense Innovation Unit (DIU), a division of the US Department of Defense (DoD), has awarded Owlstone Medical a contract for ‘Exhaled Breath Diagnostics’, focused on the early detection of human infection using volatile organic compounds (VOCs) on breath. Under the EXHALE project the company will develop a handheld device capable of non-invasive detection of pre-symptomatic respiratory infectious disease.
For warfighters operating in remote environments where access to medical personnel is limited, the risk of detecting and contracting a respiratory disease is high and can have a severe impact on mission readiness. Most current diagnostic testing platforms are unsuitable to be deployed in the field and so there is a significant need for a portable solution.
The portable device by Owlstone will be adapted to work off battery power to detect VOCs present in exhaled breath, reducing the risk of disease transmission wherever deployed, providing a strategic advantage to the force.
Based on the Company’s proprietary FAIMS technology, the device will be developed over a two-year period, supported by clinical studies to be performed at Duke University. Initial work will focus on identifying and validating breath biomarkers for viral and bacterial pathogens and defining performance requirements for the device.
If successful, there is potential for a second phase to the project for further development of the device to the point of being ready for high-volume manufacturing by Owlstone and global deployment in the field.
Billy Boyle, co-founder and CEO at Owlstone Medical, said: “We have completed multiple studies in lung inflammation and bacterial and viral infectious disease (including COVID) with major pharma and academic partners, providing us with a broad list of candidate biomarkers for consideration in this project. We have a proprietary technology in FAIMS and extensive experience with device development and sensor design, including in small handheld devices. With proven expertise and technology in both areas, we believe Owlstone is uniquely positioned to support the EXHALE project and are pleased that the DIU agrees and has awarded us this contract.”
More information online
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



